enoyl-ACP reductase

en·o·yl-ACP re·duc·tase

(ēn'ō-il rē-dŭk'tās),
An enzyme that catalyzes hydrogenation of acyl-ACP (where ACP is acyl-carrier protein) complexes to 2,3-dehydroacyl-ACPs, with NAD+ as hydrogen acceptor; important in fatty acid metabolism.
References in periodicals archive ?
Choudhary, Methylenebissantin: A rare methylene-bridged bisflavonoid from Dodonaea viscosa which inhibits Plasmodium falciparum enoyl-ACP reductase. Bioorg.
Deletion or inhibition of critical FAS-II elongation enzymes such as PfFabl (enoyl-ACP reductase), PfFabZ ([beta]-hydroxyacyl-ACP dehydratase) and pfFabG ([beta]-ketoacyl-ACP reductase) prevents the proceeding of the subsequent blood stage infection, thus the clinical symptoms of the disease (Min et al.
Marchantin A did not inhibit the reductases Pffabl (enoyl-ACP reductase) or PfFabG ([brta]-ketoacyl-ACP reductase) enzymes ([IC.sub.50] values > 100 [micro]M).
Enoyl-ACP reductase (FabI) is a key enzyme of the type II fatty acid biosynthesis (FAS-II) pathway and validated antimicrobial target.
Keywords: Algae; Trypanosoma; Leishmania; Plasmodium; Fatty acid synthase; Enoyl-ACP reductase (FabI)
The unique enzyme enoyl-ACP reductase (FabI) of Plasmodium commits the final reduction step during the fatty acid elongation process, therefore representing an excellent target for the development of novel antiplasmodial agents (Surolia and Surolia, 2001).
falciparum enoyl-ACP reductase (FabI) inhibition assay
Inhibiting activities of the secondary metabolites of Phlomis brunneogaleata against parasitic protozoa and plasmodial enoyl-ACP reductase, a crucial enzyme in fatty acid biosynthesis.
Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum.